Understanding how R loops cause genome instability in Wiskott-Aldrich syndrome

Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome

NIH-funded research Pennsylvania State Univ Hershey Med Ctr · NIH-10764289

This study is looking at how certain changes in the WAS gene might mess with the balance of R loops in immune cells, which could help explain why people with Wiskott-Aldrich syndrome have immune problems, and it aims to find new ways to understand and address these issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr NIH-funded
Lab location1 site (Hershey, United States)
Project IDNIH-10764289 on NIH RePORTER

What this research studies

This research investigates the role of R loops, which are structures formed during DNA transcription, in causing genome instability associated with Wiskott-Aldrich syndrome (WAS). The study focuses on how mutations in the WAS gene affect the balance of R loops in T helper cells, potentially leading to immune deficiencies. By examining the mechanisms that regulate R loops and their impact on DNA stability, the research aims to uncover new insights into the underlying causes of WAS and related immunological disorders. The approach includes using a disease model to explore the nuclear functions of the WAS protein and its influence on chromatin dynamics.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Wiskott-Aldrich syndrome or related primary immunodeficiency disorders.

Not a fit: Patients with unrelated genetic disorders or those not diagnosed with immunodeficiency may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with Wiskott-Aldrich syndrome and similar immune disorders.

How similar studies have performed: While the specific focus on R loops in Wiskott-Aldrich syndrome is novel, related research has shown success in understanding DNA damage mechanisms in other immunological disorders.

Where this research is happening

Hershey, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancersneoplasm/cancer
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.